Valneva SE (VALN) Short term Debt (2020 - 2025)
Valneva SE's (VALN) quarterly Short term Debt came in at $20.8 million in Q4 2025, down 6.46% year-on-year from $22.3 million in Q4 2024, and down 6.46% quarter-over-quarter from $22.3 million in Q4 2024.
Valneva SE (VALN) Short term Debt (2020 - 2025) Analysis & Trends
Valneva SE has disclosed Short term Debt across 6 years of filings, most recently posting $20.8 million for Q4 2025.
- Short term Debt for Q4 2025 came in at $20.8 million, down 6.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.8 million (down 6.46% YoY), and the FY2025 annual result was $20.8 million, down 6.46% from the prior year.
- Short term Debt came in at $20.8 million for Q4 2025 at Valneva SE, down from $22.3 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $47.4 million in Q4 2023 to a low of $8.1 million in Q4 2021.
- The 5-year median for Short term Debt is $21.1 million (2024), against an average of $22.0 million.
- Across the five-year window, Short term Debt jumped 301.43% in 2023 and sank 53.02% in 2024, its largest moves.
- Valneva SE's Short term Debt stood at $8.1 million in 2021, then surged by 45.32% to $11.8 million in 2022, then surged by 301.43% to $47.4 million in 2023, then slumped by 53.02% to $22.3 million in 2024, then slipped by 6.46% to $20.8 million in 2025.
- The last three Short term Debt figures came in at $20.8 million (Q4 2025), $22.3 million (Q4 2024), and $21.4 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.84 Mn |
| Dec 31, 2024 | 22.28 Mn |
| Jun 30, 2024 | 21.39 Mn |
| Dec 31, 2023 | 47.43 Mn |
| Dec 31, 2022 | 11.81 Mn |
| Dec 31, 2021 | 8.13 Mn |
| Dec 31, 2020 | 8.33 Mn |